APS (Adapter Protein with PH and SH2 domains) is a crucial signaling protein involved in various cellular processes, primarily functioning as an adaptor molecule in intracellular signaling pathways. Its role is to relay extracellular signals from cell surface receptors to downstream effector molecules, thereby mediating cellular responses to external stimuli. APS contains multiple domains, including a pleckstrin homology (PH) domain and a Src homology 2 (SH2) domain, which facilitate its interactions with other signaling proteins and enable its regulatory functions within signaling cascades.
Activation of APS typically occurs in response to ligand binding to cell surface receptors, such as receptor tyrosine kinases (RTKs) or cytokine receptors. Upon ligand binding, these receptors undergo conformational changes and autophosphorylation, leading to the recruitment and activation of downstream signaling proteins, including APS. The PH domain of APS facilitates its recruitment to the plasma membrane, where it interacts with phosphoinositides generated by receptor activation. Subsequently, the SH2 domain of APS binds to phosphorylated tyrosine residues on activated receptors or other adaptor proteins, leading to the phosphorylation of APS itself. This phosphorylation event induces a conformational change in APS, exposing binding sites for downstream effector molecules, such as PI3-kinase and Grb2-associated binder (Gab), thereby facilitating the propagation of signaling cascades.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Stimulates insulin receptor and downstream signaling, in which APS can play an adaptor role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can indirectly modulate pathways involving APS. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that might influence APS-associated signaling. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK2 inhibitor, which can modulate signaling pathways involving APS. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, affecting MAPK pathways potentially linked with APS activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
P38 MAPK inhibitor, influencing pathways that APS might be associated with. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that might indirectly affect signaling pathways intertwined with APS. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Influences AMPK and mTOR pathways, potentially having an indirect impact on APS signaling. | ||||||